Purpose: To determine whether exercise training might exert anti-inflammatory effect by reducing HMGB1 levels in women with breast cancer (BC).
Introduction
Breast cancer (BC) is the most common cancer in women worldwide. It is also the principle cause of death from cancer among women globally. Studies on lifestyle and occurrence of BC indicate a key role for diet and physical activity; evidence is available on the potential influence of dietary modification on BC risk [1] . Data from the large European Investigation into Cancer and Nutrition (EPIC Study), which include Italian sub-cohorts are consistent with these main findings [2] [3] [4] [5] [6] [7] ; moreover the observational analysis on BC risk from the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) suggested that dietary recommendations was associated with reduced BC incidence in those individuals mostly adherent to the recommendations [8] .
Epidemiological studies have also investigated and quite consistently reported a possible effect of physical activity on the incidence of primary BC [10] [11] [12] [13] [14] . In secondary prevention after BC diagnosis, observational studies consistently showed that the level of physical activity of BC women was corExercise training reduces high mobility group box-1 protein levels in women with breast cancer: findings from the DIANA-5 study related to an improvement in several cancer-related outcomes. Several studies including physical intervention have also suggested that a formal program of exercise training is also able to improve several cancer-related outcomes in BC survivors [15] [16] [17] [18] . Inflammation plays a crucial role in the development and evolution of cancer. Among several markers of inflammation, the high-mobility group box 1 protein (HMGB1) is emerging as a potential important mediator. HMGB1 is a highly conserved nuclear protein, acting as a chromatin-binding factor that binds DNA and promotes access to transcriptional protein assemblies on specific DNA targets [19, 20] . Besides its nuclear role, HMGB1 also functions as an extracellular signaling molecule during inflammation, cell differentiation, cell migration, and tumor metastasis [19] [20] [21] [22] . HMGB1 has been implicated in disease states, including sepsis [23] , ischemia-reperfusion [24, 25] , arthritis [26] , meningitis [27] , neurodegeneration [28] , aging [29] , and cancer [30, 31] . In cancer, overexpression of HMGB1 is associated with each of the hallmarks of cancer [32] . Increased HMGB1 protein expression is found in primary human breast carcinomas compared with normal tissues, with HMGB1 mRNA present during mouse mammary development and with low amounts measured during periods of apoptotic activity [33] .
To the best of our knowledge, the serum levels of HMGB1 and their changes after exercise interventions in women with BC have never been reported. Therefore, this study tested the hypothesis that exercise training might exert anti-inflammatory effect by reducing HMGB1 levels in BC women belonging to the DIANA-5 cohort.
Methods

Study population
The DIANA (Diet and Androgens)-5 study is a multicentre randomized controlled trial of the effectiveness of a diet based on Mediterranean and macrobiotic recipes and principles, associated with moderate physical activity, in reducing additional breast cancer (BC) events in women with early stage invasive BC at high risk of recurrence because of metabolic or endocrine milieu [34] . The overall design of the study has been described elsewhere [34] . We analyzed monocentric data (University of Naples "Federico II") consisting of 94 patients randomized into two groups: 61 patients (53±8 yrs, training group) were assigned to a structured exercise training intervention (3 times/week for the first 3 months, and once /week for the following 9 months); whereas 33 patients (52±7 yrs, control group) received only general recommendations to adhere to the life-style intervention suggestions of the DIANA protocol. The study was conducted according to the guidelines of the Declaration of Helsinki, and our institutional ethical committee approved the protocol. The purpose of the protocol was explained to the patients and written informed consent was obtained from each patient before inclusion.
Study protocol
At the study enrollment and after 12 months, all patients underwent anthropometrical and biochemical assessment, cardiovascular clinical examination, and cardiopulmonary exercise stress testing. Before randomization, all women received a leaflet illustrating the WCRF/AICR recommendations for cancer prevention [35] . Training group patients were administered both the dietary and exercise training program as detailed below. After randomization, only the intervention group (training group, 61 patients) underwent, in addition to exercise training sessions, a counseling dietary program supported by cooking classes, reinforcing meetings and print materials. The counseling program aimed at increasing leisure-time physical activity level, controlling weight, and promoting a healthy and low calorie diet. Control group (33 patients) received only general recommendations on life-style.
Anthropometrical and biochemical assessment
Body mass index (BMI) was used as a general measure of obesity and was calculated at the final visit as weight (kilograms) divided by height (meters squared). Waist circumference (WC), an index of abdominal obesity, was measured midway between the bottom of the rib cage and the top of the iliac crest. Blood pressure was measured twice after 5 min rest using a mercury sphygmomanometer. Anthropometric measurements were made with the subjects in indoor clothing and without shoes. Blood specimens were collected after 12-to 14-h fast, from 08:00 to 09:30 hours, to reduce the influence of circadian variation. Total cholesterol, triglyceride and high-density lipoprotein (HDL) cholesterol levels were measured using standard enzymatic methods [36] . Low-density lipoprotein (LDL) cholesterol was calculated according to the Friedewald formula. Fasting glucose levels were enzymatically determined by the peroxidase method. Fasting insulin levels were determined by enzyme immunoassay (Ultrasensitive Insulin Elisa, Mercodia, Sweden). Apolipoprotein B and high sensitivity C-reactive protein (hs-CRP) were measured with turbidimetric assay, using automated methods (Pentra 400 ABX Horiba, Italy). The error of the method was evaluated daily by analyzing a plasma pool and was <5%. The homeostatic assessment model (HOMA) index was used to estimate insulin resistance and calculated as fasting serum insulin (mU/L) x fasting serum glucose (mM)/22.5, as previously described [37] . Fasting HMGB1 levels were determined by enzyme immunoassay (HMGB1 Elisa, IBL International, Germany). Fasting high sensitivity IL-6 levels were determined by enzyme immunoassay (IL-6 Elisa, Diaclone, France). The inter-assay as well as the intra-assay coefficient was <10%.
Cardiopulmonary exercise training testing
Respiratory gas exchange measurements were obtained breath by breath with the use of a computerized metabolic cart (Vmax 29C, Sensormedics, Yorba Linda, CA, USA) as detailed elsewhere [24] . Briefly, after a 1-min warm-up period at 0 Watts workload, a ramp protocol of 20 W/min was started and continued until exhaustion. The pedaling was kept constant at 55-65 revolutions/min. A 12-lead electrocardiogram (ECG) was monitored continuously during the test, and cuff blood pressure was manually recorded every 2 min. VO 2peak was recorded as the mean value of VO 2 during the last 20s of the test and was expressed in milliliters per kilogram per minute. Predicted VO 2peak was determined by use of a sex-, age-, height-and weight-adjusted and protocol-specific formula as previously detailed [24] . The ventilatory anaerobic threshold (VAT) was detected by use of the V-slope method. The VE versus VCO 2 relationship was measured by plotting ventilation (VE) against carbon dioxide production (VCO 2 ) obtained every 10s of exercise (VE/VCO 2 slope): both VE and VCO 2 were measured in liters per minute. The VE/VCO 2 slope was calculated as a linear regression function, excluding the non-linear part of the relationship after the onset of acidotic drive to ventilation [24] .
Exercise training program and cooking session
Training group patients were enrolled in an inhospital structured exercise training program. The frequency goals of in-hospital exercise training sessions was 3 times/week for the first 3 months, and once /week for the following 9 months. Each session consisted of cycle or treadmill 30 min exercise, preceded by 5 min of warming and followed by 5 min of cooling down, at a work load of 75% of baseline peak VO 2 . This structured exercise training was on top of the general leisure-time physical activity recommendations or prescription of the general DIANA study (questionnaires, caloric control, etc, see above). From the 4th month to the 12th month, in-hospital exercise training sessions were reduced to one session/week, integrated with general leisure-time physical activity sessions, according to recommendations and prescription of the general DIANA study [34] . Training group was subdivided into 3 subgroups according to the adhesion to the in-hospital exercise training sessions: no sessions (group 1); 1 to 45 sessions per year (group 2); 46 to 130 sessions per year (group 3). During cooking sessions, patients were invited cooking and eating some dishes prepared according to the WCRF/AICR recommendations and inspired by a macrobiotic Mediterranean diet [35] . 
Statistical Methods
Continuous
Results
Baseline characteristics of the study population are shown in Table 1 . There were no significant differences between groups in baseline anthropometrical, BC characteristics, metabolic and inflammatory profile (Table 1) .
The study period was similar in both groups. In training group, the average exercise intensity was 74.4±2.3% of baseline VO 2peak . No adverse events took place during any of training sessions in BC patients undergoing exercise training sessions.
Among the training group, 24 patients had very low adherence to the exercise intervention sessions, whereas 19 patients had high adherence. After stratifying the study population according to the level of adhesion to the exercise intervention sessions, 1-year HMGB1 levels were lower among patients more adherent (p for trend=0.001) ( Table 2 ). After adjusting for age, body mass index and baseline values, 1-year HMGB1 levels were significantly and inversely associated to the level of adhesion to the exercise intervention (B=-0.97, SE=0.43, p=0.01) ( Table 3) . No significant correlations between exercise intervention and the other inflammatory mediators (hs-CRP and IL-6) were found ( Table 3) .
Discussion
To the best of our knowledge, this is the first study demonstrating an exercise training-induced reduction of HMGB1 levels in BC women. Notably, the reduction of HMGB1 levels is strongly correlated to the level of adhesion to exercise program and is more sensitive than that of other systemic inflammatory mediators such as hs-CRP and IL-6.
In cancer, overexpression of HMGB1 is associated with each of the hallmarks of cancer including unlimited replicative potential, angiogenesis, reduction of apoptosis, self-sufficiency in growth signals, and insensitivity to inhibitors of growth, inflammation, tissue invasion and metastasis [30] . In primary human breast carcinomas, increased HMGB1 protein expression has been found compared with normal tissues, with HMGB1 mRNA present during mouse mammary development with low amounts measured during periods of apoptotic activity [33] .
The role of the immune system during cancer development is complex, involving extensive reciprocal interactions between genetically altered cells, adaptive and innate immune cells, their soluble mediators and structural components present within the tumor microenvironment. Immune system strictly regulates each stage of cancer development in most adult tumors. Whereas full activation of adaptive immune cells at the overt invasive tumor stage may result in eradication of malignant cells, chronic activation of innate immune cells at sites of premalignant growth may actually enhance tumor development. In addition, the balance between desirable antitumor immune responses and undesirable pro-tumor chronic inflammatory responses largely depends on the context in which a malignancy is developing [39] . HMGB1 alerts the innate immune system to stress and excessive or unregulated cell death [40, 41] . Captions: HOMA, homeostatic assessment model; LDL, low-density lipoprotein; HDL, high-density lipoprotein; hsCRP, high sensitivity C-reactive protein; IL-6, interleukin-6; HMGB1, high mobility group box-1. Values are mean and standard deviation; * values were median and range, p-value from Tobit model.; § 0 = not detectable Captions: LDL, low-density lipoprotein; HDL, high-density lipoprotein; hsCRP, high sensitivity C-reactive protein; IL-6, interleukin-6; HMGB1, high mobility group box-1.
HMGB1 mediates a number of important functions including stimulating the release of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and other inflammatory products, endothelial cell activation, recruitment and activation of innate immune cells, and also dendritic cell maturation that, in the setting of cancer, lead to a chronic inflammatory response [21] . Epidemiological studies have shown that the level of physical exercise is associated to improved outcome in BC patients, included cancer related and total mortality [11] [12] [13] [14] . Moderate intensity exercise interventions in postmenopausal breast cancer (i.e. 60% VO 2peak ) are associated with several favorable effects in several cancer-related outcomes, such as physical and psychological function and quality of life [42, 43] . Several factors mediate the relationship between exercise, inflammation and immune system. The individual characteristics, type and intensity of exercise, as well as the timing of cancer diagnosis and stage may have an interplay role. Both the incidence of cancer, chronic inflammatory status and the impairment of the immune system also show negative age-related changes that can partially be counteracted with exercise [44] . Weight loss, reduced levels of insulin, glucose, and sex hormones, decreased inflammation and immunostimulation might also explain the beneficial effects of exercise on cancer outcomes [15-18, 45, 46] . However, these effects mainly depend on type and duration of exercise; and the clinically relevant cut-off points of the exercise-induced anti-inflammatory response are still largely unknown within the context of cancer. In fact, it should be noted that reduced inflammatory status, enhanced immune function and low susceptibility to cancer occur with regular moderate exercise, whereas sedentary habits and exhaustive exercise suppress immune system inducing a pro-inflammatory state and higher oxidative DNA damage, both of which are hypothesized to be markers of cancer recurrence [47] . The present study showed that the reduction of HMGB1 is proportional to the level of adherence to 1-year exercise intervention of moderate intensity; whereas no effect was found on other classical inflammatory molecules such as hs-CRP or IL-6. It could be hypothesized that exercise training may exert an early anti-inflammatory effect mediated by HMGB1 at nuclear level. Whether exercise-induced reduction of HMGB1 might have prognostic impact on BC survivors should be investigated.
Study limitations
A number of limitations of the present study should be considered. Training patients underwent moderate intensity exercise program: whether an exercise program of higher intensity might have additional clinical and prognostic value should be clarified. Moreover, exercise training attendance was good in 19 out of 61 patients, highlighting the gender specific difficulties in attending long-term exercise training programs as previously described in women with cardiovascular disease attending cardiac rehabilitation programs [48] . Despite the aforementioned limitations, this study has several unique strengths. This is the first study enrolling high-risk BC survivors (women with early stage invasive BC at high risk of recurrence because of metabolic or endocrine milieu) to 1-year exercise intervention, and the first to demonstrate a reduction of a potent inflammatory marker such as the HMGB1 protein in these high risk patients.
Conclusions
Moderate intensity exercise training in BC survivors is associated with reduced HMGB1 levels that are proportional to the level of adhesion to the exercise program. The correlation to exercise dose is more sensitive than that observed for other systemic inflammatory mediators such as hs-CRP and IL-6. These results confirm that exercise training-n favorably modulate the inflammatory status in high risk BC patients. Further studies are needed in order to evaluate whether the reduction of HMGB1 levels has prognostic value in BC women. 
